Antiproliferative and survival properties of PMA in MCF-7 breast cancer cell

V Fortino1, C Torricelli, E Capurro

  • 1Department of Physiology, University of Siena, Siena, Italy.

Cancer Investigation
|January 9, 2008
PubMed

Insights

Phorbol esters (PMA) induce growth arrest and inhibit cell death in MCF-7 breast cancer cells by activating ERKs, leading to p21 induction. This survival effect is ERK-dependent and p53-independent.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Phorbol esters (PMA) are known to target protein kinase C (PKC) pathways.
  • Other effectors like chimaerins and RasGRP can modulate PKC activity.
  • Understanding PMA's full impact on cancer cells is crucial.

Purpose of the Study:

  • To investigate the proliferative behavior of MCF-7 breast cancer cells treated with PMA.
  • To elucidate the molecular mechanisms underlying PMA's effects on cell growth and survival.

Main Methods:

  • Treatment of MCF-7 cells with PMA.
  • Analysis of cell proliferation and death.
  • Western blotting to detect protein expression (e.g., p21).
  • Use of specific inhibitors for ERK (PD98059) and PKC (GF109203X).

Main Results:

  • PMA induced significant growth arrest and inhibited cell death in MCF-7 cells.
  • PMA treatment led to the activation of Extracellular signal-Regulated Kinases (ERKs).
  • Activated ERKs subsequently induced the expression of p21.
  • Inhibiting ERK or PKC pathways abolished p21 induction and the PMA-mediated survival effect.

Conclusions:

  • PMA exerts a dual effect on MCF-7 cells: inhibiting growth while promoting survival.
  • Both growth inhibition and survival stimulation are mediated by ERK-dependent p21 induction.
  • The observed p21 induction is independent of the p53 pathway.